Molecule Mind
PrivateLast Round
Series A
Sep 13, 2024
Total Funding Raised
$114.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Molecule Mind operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A round in September 2024.
Molecule Mind is a biotechnology company that develops an AI-driven platform for protein prediction, optimization, and design.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecule Mind Comparables
Compare Molecule Mind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chai Discovery | 84% | |
| Insilico Medicine | 79% | |
| Chan Zuckerberg Biohub | 79% |
For institutional investors. Book with your work email.
Molecule Mind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 13, 2024 | ||||
| Series A | Jan 21, 2024 | ||||
| Strategic | Feb 20, 2023 | ||||
| Angel | Apr 18, 2022 |
For institutional investors. Book with your work email.
Molecule Mind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A |
| 联想创投集团 (Lenovo Capital and Incubator Group) | Strategic |
| Baidu Ventures | Angel |
| Zhongguancun Development Group | Angel |
| Infinity Group | Series A |
| HongShan Capital Group (HSG) | Angel, Strategic |
| Shenzhen Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Grew 24% QoQ from 21 to 26 employees.
- Jul 24, 2026
Monthly visitors grew 183% MoM, reaching 3.1K.
For institutional investors. Book with your work email.
Molecule Mind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Molecule Mind's valuation, stock price, and market status.
Is Molecule Mind a public or private company?
Molecule Mind is a private company.
What is the current stock price of Molecule Mind?
Molecule Mind is a private company, so its shares have no public market price. Caplight tracks Molecule Mind's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Molecule Mind worth (valuation)?
Valuation information for Molecule Mind is not publicly available.
Can I buy Molecule Mind stock?
Molecule Mind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Molecule Mind's last funding round?
Molecule Mind's most recent funding round was Series A on September 13, 2024.
Who are the main investors in Molecule Mind?
Key investors in Molecule Mind include Shenzhen Capital Group.
Will Molecule Mind IPO soon?
No public IPO plans have been announced for Molecule Mind.
How can I track Molecule Mind secondary market activity?
Caplight tracks bids, offers, and trades in Molecule Mind's shares on secondary markets.